Cefuroxime axetil at 500 mg is a widely prescribed oral antibiotic used to treat bacterial infections of the lungs, sinuses, ears, urinary tract, skin, and soft tissue, and it is also one of the recommended drugs for early Lyme disease. It belongs to the second-generation cephalosporin family and works by disrupting bacterial cell-wall construction. What makes cefuroxime axetil unusual among antibiotics is that it is a prodrug: the tablet itself is not the active drug, but gets converted into cefuroxime inside your body during absorption. That conversion step, along with the drug’s relationship with food, kidney function, and bacterial resistance, shapes much of the practical advice around taking it.
How the Drug Gets Into Your System
Cefuroxime axetil is technically a 1:1 mixture of two mirror-image chemical forms, and enzymes in the gut wall split off an ester group during absorption to release the active compound, cefuroxime, into the bloodstream.1PubMed Central. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model This conversion happens quickly, which is why blood tests after dosing detect cefuroxime rather than the prodrug form.
One of the most clinically relevant details about this drug is how much food affects absorption. In a pharmacokinetic study of the 500 mg dose, roughly 36 percent of the drug was absorbed on an empty stomach compared with about 52 percent when taken with food, and peak blood levels were over 40 percent higher after a meal.2PubMed. Effect of dose and food on the bioavailability of cefuroxime axetil That is not a small difference. Taking cefuroxime axetil on an empty stomach can meaningfully lower the amount of active drug circulating in your blood, which could compromise how well the antibiotic works. The standard advice from prescribers is to take each dose shortly after eating.
Respiratory Infections
Community-acquired pneumonia and acute bronchitis are among the most common reasons cefuroxime axetil gets prescribed at the 500 mg strength. In one early clinical trial of hospitalized adults, 500 mg twice daily for ten days produced clinical and bacteriologic cures in 11 out of 12 pneumonia patients and 7 out of 8 bronchitis patients.3PubMed. Treatment of community-acquired lower respiratory tract infections with oral cefuroxime axetil Those are small numbers, but the pattern has held up in larger studies.
A common hospital approach involves starting a patient on intravenous cefuroxime and then switching to oral cefuroxime axetil once clinical improvement begins. A larger trial evaluating that strategy in community-acquired pneumonia found clinical response rates around 79 to 84 percent at the end of treatment, with the most frequently isolated bacteria being Streptococcus pneumoniae, Haemophilus influenzae, and Enterobacteriaceae. The drug was well tolerated, with gastrointestinal symptoms being the most common complaint.4Chest. Sequential Therapy With Cefuroxime Followed by Cefuroxime Axetil in Community-Acquired Pneumonia This IV-to-oral switch approach lets patients leave the hospital sooner while staying on the same antibiotic class throughout treatment.
Sinusitis, Pharyngitis, and Ear Infections
Cefuroxime axetil has been extensively studied for sinus infections. Across 18 clinical trials involving over 1,500 patients with acute sinusitis or flare-ups of chronic sinusitis, 250 mg twice daily produced satisfactory outcomes (cure or improvement) in 79 to 100 percent of patients and bacterial eradication in 84 to 100 percent. Twelve of those trials directly compared cefuroxime axetil to other common antibiotics including amoxicillin, amoxicillin-clavulanate, and clarithromycin, and the results were consistently similar.5PubMed. Cefuroxime axetil in the treatment of sinusitis. A review. For adults with sinusitis, the 250 mg dose is the more typical prescription, though prescribers may step up to 500 mg for more severe presentations.
For strep throat in children, a shorter course of cefuroxime axetil has been compared head-to-head with the traditional ten-day penicillin course. In one trial, just four days of cefuroxime axetil eradicated the bacteria in about 88 percent of children, matching penicillin’s eradication rate almost exactly. Clinical cure rates were similarly close, and symptoms actually resolved faster in the cefuroxime group.6PubMed. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children A shorter course is appealing because children are more likely to complete it, though guidelines in different countries vary on whether four or five days is sufficient for strep.
It is worth noting that antibiotics do not always outperform watchful waiting for sinus symptoms. A randomized, placebo-controlled trial in children with acute respiratory illness and imaging evidence of sinusitis found no meaningful difference between ten days of cefuroxime axetil and placebo in the proportion of children fully cured by day 14.7PubMed. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial This fits the broader understanding that many sinus infections are viral and will resolve without antibiotics, which is why prescribers are generally encouraged to reserve antibiotics for cases with persistent or worsening symptoms.
Urinary Tract Infections
Uncomplicated lower urinary tract infections in women are another established indication. In a study of 75 women, a once-daily 250 mg dose for ten days cleared the infecting organism in 93 percent of patients at the end of treatment and 98 percent at six-week follow-up. The overall cure rate including reinfections was 86 percent. The most common side effects were yeast infections (in about 11 percent) and diarrhea (in about 5 percent).8PubMed. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil
Shorter courses have also been tested. A multicenter trial compared three days of low-dose cefuroxime axetil (125 mg twice daily) against three days of the fluoroquinolone ofloxacin for acute uncomplicated bladder infections. Clinical cure or improvement occurred in about 85 percent of cefuroxime patients versus 95 percent of ofloxacin patients, a difference that was not statistically significant.9PubMed. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women In current practice, the choice of antibiotic for a bladder infection depends heavily on local resistance patterns. Where resistance to first-line agents like trimethoprim-sulfamethoxazole is high, cefuroxime axetil becomes a reasonable alternative.
Skin and Soft Tissue Infections
Bacterial skin infections such as cellulitis, wound infections, and abscesses are frequently caused by Staphylococcus aureus and Streptococcus species, both of which fall well within cefuroxime’s spectrum. A multicenter trial randomized 125 outpatients with skin infections to either cefuroxime axetil (250 mg or 500 mg twice daily) or cefaclor (another oral cephalosporin). Clinically beneficial outcomes were achieved in 92 percent of the lower-dose cefuroxime group and 95 percent of the 500 mg group, results comparable to cefaclor’s 97 percent.10PubMed. Cefuroxime axetil in the treatment of cutaneous infections A separate general-practice study using a seven-day course of 250 mg twice daily reported clinical improvement in 95 percent of patients with various skin and soft tissue infections.11International Journal of Clinical Practice. Is oral cefuroxime axetil suitable for the treatment of unidentified bacterial infection of skin and soft tissue?
Early Lyme Disease
Cefuroxime axetil at 500 mg twice daily for 14 to 21 days is one of the standard treatments for early Lyme disease, particularly when doxycycline cannot be used (for example, in pregnant women or young children). Two randomized trials have compared the two drugs directly. In one, cefuroxime axetil was “equally as effective as doxycycline in the treatment of early Lyme disease and in preventing the subsequent development of late Lyme disease.”12PubMed. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease The second trial reported a satisfactory outcome in 90 percent of cefuroxime-treated patients versus 95 percent of doxycycline-treated patients, a gap that fell within the range of statistical equivalence.13PubMed Central. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans In practice, doxycycline remains the first choice for most adults because it is cheaper and covers certain co-infections, but cefuroxime axetil is the go-to alternative.
Common Side Effects
Cefuroxime axetil is generally well tolerated, and its side-effect profile is typical of oral cephalosporins. The most frequently reported issues are gastrointestinal: nausea, diarrhea, and abdominal discomfort. As the UTI study noted, yeast infections (vaginal candidiasis) can occur, which is a consequence of any broad-spectrum antibiotic disturbing the body’s normal bacterial balance.8PubMed. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil Across the respiratory and skin infection trials cited above, drug-related adverse events were consistently described as mild and infrequent, with GI symptoms topping the list.
One practical complaint that deserves mention is the drug’s intensely bitter taste, especially in liquid formulations for children. This bitterness has driven substantial pharmaceutical research into taste-masking techniques. One approach uses a solid dispersion with stearic acid, which not only masks the taste but also roughly doubled the oral bioavailability compared with a standard suspension in testing.14ScienceDirect (Asian Journal of Pharmaceutical Sciences). Development and evaluation of taste-masked dry suspension of cefuroxime axetil for enhancement of oral bioavailability For tablet users this is less of an issue, but parents of young children often struggle to get them to swallow the liquid form. Crushing the tablet and mixing it with food is sometimes suggested, though this can also release the bitter taste.
Allergies and Penicillin Cross-Reactivity
Because cephalosporins and penicillins share a core chemical structure called the beta-lactam ring, people with penicillin allergies sometimes worry about cephalosporins. The reality is more nuanced than a blanket warning. Allergic reactions to cephalosporins can stem from the shared ring or from side chains unique to each drug.15PubMed Central. Cephalosporins’ Cross-Reactivity and the High Degree of Required Knowledge. Case Report and Review of the Literature. Cross-reactivity between penicillins and cephalosporins depends largely on how similar those side chains are.
This is where cefuroxime has an advantage. Amoxicillin is the penicillin most commonly involved in immediate allergic reactions, and among cephalosporins, the one most likely to cross-react with amoxicillin is cefadroxil, because the two drugs share the same R1 side chain. Cefuroxime has a structurally different R1 side chain, which means its cross-reactivity risk with amoxicillin is lower.16PubMed Central. Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes If you have had a mild, non-life-threatening reaction to amoxicillin, many allergists will consider cefuroxime axetil a reasonable option with appropriate monitoring. A history of severe anaphylaxis to any penicillin still warrants extra caution and allergist evaluation before taking any cephalosporin.
Kidney Function and Dose Adjustments
Cefuroxime is eliminated primarily through the kidneys, so impaired kidney function slows the drug’s clearance and raises blood levels. A pharmacokinetic study found a strong linear relationship between kidney clearance and the drug’s elimination rate. Based on those findings, no dose adjustment is needed when creatinine clearance is above 50 mL/min. Below that threshold, the same individual dose should be given less frequently: every 12 hours for moderate impairment, every 24 hours for more severe impairment, and every 48 hours for very poor kidney function.17PubMed. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function This matters because failing to adjust the dose in kidney disease can lead to drug accumulation and serious side effects.
Specifically, excessive cefuroxime levels in patients with renal failure have been linked to a reversible encephalopathy characterized by reduced consciousness, muscle jerks (myoclonus), and a flapping tremor (asterixis). A case series described four patients who developed this syndrome: three had renal failure and received standard doses. All recovered after the drug was stopped.18PubMed. Cefuroxime-induced encephalopathy This is a rare complication, but it underscores why prescribers check kidney function before dosing cephalosporins and why you should mention any kidney problems to your doctor or pharmacist.
Bacterial Resistance and What Cefuroxime Can and Cannot Kill
One of cefuroxime’s design strengths is its resistance to destruction by many common bacterial enzymes called beta-lactamases. These enzymes are a frequent defense mechanism bacteria use to inactivate antibiotics, and cefuroxime’s chemical stability against them played a major role in its broad activity against both gram-positive and gram-negative organisms when the drug was first developed.19PubMed Central. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity That stability is one reason cefuroxime became a workhorse antibiotic for mixed infections where both types of bacteria might be involved.
However, bacteria have not stood still. Extended-spectrum beta-lactamases (ESBLs) are a newer family of resistance enzymes produced primarily by Enterobacteriaceae, and they can break down second-generation cephalosporins like cefuroxime that older beta-lactamases could not.20PubMed Central. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment In practical terms, this means cefuroxime axetil works well against susceptible strains of common pathogens like S. aureus, E. coli, and Proteus mirabilis, but shows no activity against inherently resistant organisms like Pseudomonas aeruginosa or ESBL-producing bacteria.21PubMed Central. Quality evaluation of cephalexin, cefuroxime, and ceftriaxone medicines marketed in Addis Ababa city, Ethiopia with three tier level approach and anti-microbial assays Your prescriber will often order a culture and sensitivity test for infections that do not respond to initial treatment, and ESBL-producing bacteria are one key reason a switch to a different antibiotic class may be necessary.
Pregnancy, Breastfeeding, and Children
Cefuroxime axetil is generally considered compatible with pregnancy. Cephalosporins as a class have a long track record of use in pregnant women without evidence of teratogenicity, and cefuroxime axetil specifically is one of the recommended alternatives for treating Lyme disease during pregnancy, when doxycycline is contraindicated.
For breastfeeding, cefuroxime does pass into breast milk, though at low concentrations. Analytical methods have been developed to detect cefuroxime in breast milk at levels as low as 25 nanograms per milliliter, confirming the drug’s presence but at quantities far below therapeutic doses for an infant.22ScienceDirect (Asian Journal of Pharmaceutical Sciences). Determination of cefuroxime in breast milk by LC-MS/MS using SALLME technique Most clinical guidelines consider cefuroxime acceptable during breastfeeding, though as with any antibiotic, there is a small chance the infant could develop loose stools or thrush from disruption of gut flora.
In children, the drug is available as an oral suspension, though as mentioned, the bitter taste can be a genuine obstacle to compliance. Dosing is typically weight-based rather than a flat 500 mg adult dose. For most pediatric indications, prescribers calculate between 10 and 15 mg per kilogram per dose, given twice daily, up to the adult maximum.
How Cefuroxime Axetil Compares Within Its Class
Second-generation cephalosporins sit in a middle ground between the narrower first-generation drugs (like cephalexin, which is strong against gram-positive bacteria but limited against gram-negatives) and the broader third-generation drugs (like ceftriaxone, which covers more gram-negatives but is only available by injection). Cefuroxime axetil’s value is that it covers a reasonably broad range of common pathogens in an oral tablet you can take at home. For outpatient treatment of moderate infections, it often fills the gap between “too narrow” and “only available as an IV.”
Compared to first-generation cephalosporins, cefuroxime’s greater resistance to beta-lactamases gives it an edge against H. influenzae and certain E. coli strains that would shrug off cephalexin. But it cannot replace third-generation agents for serious gram-negative infections or hospital-acquired pathogens. It is fundamentally an outpatient drug for community-acquired infections where the likely culprits are common respiratory, urinary, or skin bacteria.
Quality of the tablet itself can also matter. A recent evaluation of cephalosporin products on the market in Addis Ababa tested cephalexin capsules, cefuroxime axetil tablets, and ceftriaxone injection powder against a panel of bacteria. Cefuroxime axetil tablets showed the highest activity against S. aureus among the three, while ceftriaxone was strongest against Proteus mirabilis, and all three were predictably ineffective against Pseudomonas and Klebsiella.21PubMed Central. Quality evaluation of cephalexin, cefuroxime, and ceftriaxone medicines marketed in Addis Ababa city, Ethiopia with three tier level approach and anti-microbial assays Results like these reinforce that cefuroxime’s strength lies in its classic targets: staphylococci, streptococci, and susceptible gram-negative rods.
Practical Tips for Getting the Most From Your Prescription
A few things can make a meaningful difference in how well cefuroxime axetil works for you:
- Take it with food. As the bioavailability data show, absorption can jump from roughly a third to over half of the dose simply by eating beforehand. Even a small snack helps.
- Finish the full course. Stopping early because you feel better is one of the most common drivers of bacterial resistance and relapse. If you experience side effects that make you want to stop, call your prescriber rather than just quitting.
- Mention kidney problems. Even mild kidney impairment can change how often you should take each dose, and your prescriber needs accurate information to set the right schedule.
- Disclose all allergies. If you have had any reaction to a penicillin or another cephalosporin, your prescriber needs to know the details, including whether it was a rash, hives, or something more severe like throat swelling or anaphylaxis. The cross-reactivity risk with cefuroxime is lower than with some other cephalosporins, but the severity of your prior reaction matters for the decision.
- Watch for signs of yeast overgrowth. Vaginal itching, white discharge, or oral thrush are not reasons to panic but are worth reporting, especially if you are on a longer course.